Milestone Pharmaceuticals Inc.
MIST
Revenue
0.00
0.000.00%
-Assets
89.23M
▼-6.77M▼-7.05%
3 Months ChangeLiabilities
57.25M
▲1.17M▲2.09%
3 Months ChangeFree Cash Flow
-13.94M
▼-9.21M▼-194.75%
60 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-04
Form 8-K
ID: 0001104659-24-096648
2024-08-08
Form 8-K
ID: 0001104659-24-087301
2024-08-08
Form 10-Q
ID: 0001558370-24-011603
2024-07-15
Form 8-K
ID: 0001104659-24-079854
2024-05-29
Form 8-K
ID: 0001104659-24-065806
2024-05-13
Form 8-K
ID: 0001104659-24-060221
2024-05-13
Form 10-Q
ID: 0001558370-24-007860
2024-04-08
Form 8-K
ID: 0001104659-24-044767
2024-03-28
Form 8-K
ID: 0001104659-24-040008
2024-03-21
Form 8-K
ID: 0001104659-24-036941